129 related articles for article (PubMed ID: 35700426)
1. Efficacy of Teicoplanin Lock Therapy in the Treatment of Port-related Coagulase-negative Staphylococci Bacteremia in Pediatric Oncology Patients.
Okur Acar S; Tahta N; Böncüoğlu E; Odaman Al I; Kiymet E; Gözmen S; Demirağ B; Karapinar TH; Oymak Y; Vergin C; Devrim İ
J Pediatr Hematol Oncol; 2023 Jan; 45(1):e17-e20. PubMed ID: 35700426
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of teicoplanin versus vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis.
Del Pozo JL; García Cenoz M; Hernáez S; Martínez A; Serrera A; Aguinaga A; Alonso M; Leiva J
Int J Antimicrob Agents; 2009 Nov; 34(5):482-5. PubMed ID: 19713086
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of teicoplanin in the treatment of bloodstream infection caused by methicillin-resistant coagulase-negative staphylococci.
Yamada K; Ueda T; Nakajima K; Ichiki K; Tsuchida T; Otani N; Takahashi Y; Ikeuchi H; Uchino M; Koshiba M; Takesue Y
J Infect Chemother; 2020 May; 26(5):459-464. PubMed ID: 31870587
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics of Methicillin-resistant Coagulase-negative Staphylococcal Bacteremia in a Tertiary Hospital.
Yamada K; Namikawa H; Fujimoto H; Nakaie K; Takizawa E; Okada Y; Fujita A; Kawaguchi H; Nakamura Y; Abe J; Kaneko Y; Kakeya H
Intern Med; 2017; 56(7):781-785. PubMed ID: 28381743
[TBL] [Abstract][Full Text] [Related]
5.
Blanco-Di Matteo A; Garcia-Fernandez N; Aguinaga Pérez A; Carmona-Torre F; Oteiza AC; Leiva J; Del Pozo JL
Antimicrob Agents Chemother; 2023 Jan; 67(1):e0126422. PubMed ID: 36602372
[TBL] [Abstract][Full Text] [Related]
6. Local antibiotic lock for the treatment of infections related to central catheters in parenteral nutrition in children.
Cuntz D; Michaud L; Guimber D; Husson MO; Gottrand F; Turck D
JPEN J Parenter Enteral Nutr; 2002; 26(2):104-8. PubMed ID: 11871733
[TBL] [Abstract][Full Text] [Related]
7. Comparing ethanol lock therapy versus vancomycin lock in a salvation strategy for totally implantable vascular access device infections due to coagulase-negative staphylococci (the ETHALOCK study): a prospective double-blind randomized clinical trial.
Lesens O; Forestier E; Botelho-Nevers E; Pavese P; David G; Nougarede B; Corbin V; Pereira B; Aumeran C; Sauvat L
Eur J Clin Microbiol Infect Dis; 2024 Feb; 43(2):223-232. PubMed ID: 37993679
[TBL] [Abstract][Full Text] [Related]
8. Oral minocycline as systemic therapy for uncomplicated venous access device-related bloodstream infection with coagulase-negative staphylococci after allogeneic hematopoietic cell transplantation.
Bayoudh F; Giot JB; Descy J; Fontaine C; Hayette MP; Baron F; Willems E; Beguin Y; Frippiat F; Servais S
Curr Res Transl Med; 2024 Mar; 72(1):103422. PubMed ID: 38244302
[TBL] [Abstract][Full Text] [Related]
9. Outcome of antibiotic lock technique for persistent central venous catheter-associated coagulase-negative Staphylococcus bacteremia in children.
Megged O; Shalit I; Yaniv I; Fisher S; Livni G; Levy I
Eur J Clin Microbiol Infect Dis; 2010 Feb; 29(2):157-61. PubMed ID: 19911207
[TBL] [Abstract][Full Text] [Related]
10.
Plota M; Papadimitriou-Olivgeris M; Kolonitsiou F; Tsiata E; Spiliopoulou I; Assimakopoulos SF; Marangos M
J Med Microbiol; 2021 Sep; 70(9):. PubMed ID: 34559042
[No Abstract] [Full Text] [Related]
11. Central venous catheter-associated bloodstream infections in pediatric hematology-oncology patients and effectiveness of antimicrobial lock therapy.
Tsai HC; Huang LM; Chang LY; Lee PI; Chen JM; Shao PL; Hsueh PR; Sheng WH; Chang YC; Lu CY
J Microbiol Immunol Infect; 2015 Dec; 48(6):639-46. PubMed ID: 25311403
[TBL] [Abstract][Full Text] [Related]
12. [Bacteremia caused by coagulase-negative staphylococci: incidence, frequency of teicoplanin resistance and molecular epidemiology].
Bertrand X; Lallemand S; Thouverez M; Boisson K; Talon D
Pathol Biol (Paris); 2002 Nov; 50(9):552-9. PubMed ID: 12490419
[TBL] [Abstract][Full Text] [Related]
13. Is antibiotic lock therapy effective for the implantable longterm catheter-related bloodstream infections in children?
Kara TT; Özdemir H; Erat T; Yahşi A; Aysev AD; Taçyıldız N; Ünal E; İleri T; İnce E; Haskoloğlu Ş; Çiftçi E; İnce E
Turk J Pediatr; 2019; 61(6):895-904. PubMed ID: 32134584
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of antibiotic-lock technique with teicoplanin in staphylococcus epidermidis catheter-related sepsis during long-term parenteral nutrition.
Guedon C; Nouvellon M; Lalaude O; Lerebours E
JPEN J Parenter Enteral Nutr; 2002; 26(2):109-13. PubMed ID: 11871734
[TBL] [Abstract][Full Text] [Related]
15. Teicoplanin-resistant coagulase-negative staphylococcal bacteraemia in patients with haematological malignancies: a problem of increasing importance.
Pagano L; Tacconelli E; Tumbarello M; Laurenti L; Mele L; Spanu T; Cauda R; Fadda G; Leone G
J Antimicrob Chemother; 1997 Nov; 40(5):738-40. PubMed ID: 9421330
[No Abstract] [Full Text] [Related]
16. Efficacy of vancomycin lock therapy for totally implantable venous access port-related infection due to coagulase-negative staphylococci in 100 patients with cancer.
Lafaurie M; Montlahuc C; Kerneis S; de Lastours V; Abgrall S; Manceron V; Couzigou C; Chabrol A; de Raigniac A; Lescure X; Longuet P; Lesprit P; Vanjak D; Lepeule R;
J Antimicrob Chemother; 2023 May; 78(5):1253-1258. PubMed ID: 37014800
[TBL] [Abstract][Full Text] [Related]
17. Relationship between glycopeptide use and decreased susceptibility to teicoplanin in isolates of coagulase-negative staphylococci.
Bertin M; Muller A; Bertrand X; Cornette C; Thouverez M; Talon D
Eur J Clin Microbiol Infect Dis; 2004 May; 23(5):375-9. PubMed ID: 15112071
[TBL] [Abstract][Full Text] [Related]
18. Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study.
Tacconelli E; Tumbarello M; Donati KG; Bettio M; Spanu T; Leone F; Sechi LA; Zanetti S; Fadda G; Cauda R
Clin Infect Dis; 2001 Nov; 33(10):1628-35. PubMed ID: 11595984
[TBL] [Abstract][Full Text] [Related]
19. Emergence of teicoplanin-resistant coagulase-negative staphylococci.
Cercenado E; García-Leoni ME; Díaz MD; Sánchez-Carrillo C; Catalán P; De Quirós JC; Bouza E
J Clin Microbiol; 1996 Jul; 34(7):1765-8. PubMed ID: 8784585
[TBL] [Abstract][Full Text] [Related]
20. Coagulase-negative staphylococcal bacteraemia treated with teicoplanin.
O'Connell B; Browne PV; Cafferkey MT; McCann SR
J Antimicrob Chemother; 1993 Mar; 31(3):438-9. PubMed ID: 8486578
[No Abstract] [Full Text] [Related]
[Next] [New Search]
